Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Glaucoma: Overview01:25

Glaucoma: Overview

1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

5.4K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
5.4K
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

3.4K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
3.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body Mass Index is Associated With Direction-Specific Increases in With-the-Rule Corneal and Refractive Astigmatism in Schoolchildren.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same author

Next-Generation Myopia Control Spectacles Hint at Defocus Opponency Circuits in the Retina.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same author

Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK).

BMJ (Clinical research ed.)·2026
Same author

Workforce challenges to implementation of myopia management in Europe: an electronic/telephone expert survey.

Frontiers in ophthalmology·2026
Same author

Low-concentration atropine for management of myopia progression: does iris colour matter?

Eye (London, England)·2026
Same author

Compensation for axial elongation during multifocal soft contact lens wear: Results from the BLINK study.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same journal

Degeneration of Interpericyte Tunneling Nanotubes Can Occur in the Absence of Pericyte Loss in Diabetic Retina Disease.

Investigative ophthalmology & visual science·2026
Same journal

Unsupervised Clustering for POAG Phenotyping.

Investigative ophthalmology & visual science·2026
Same journal

Myd88 Deficiency Accelerates Retinal Degeneration and Alters Microglial Dynamics in a Mouse Model of Retinitis Pigmentosa.

Investigative ophthalmology & visual science·2026
Same journal

Sigma 1 Receptor Activation Coordinates Metabolic Stress Responses to Protect Retinal Vasculature in Ischemic Retinopathy.

Investigative ophthalmology & visual science·2026
Same journal

On the Misuse of Virus-Transformed Human Corneal Epithelial Cells as Surrogates for Normal Cells.

Investigative ophthalmology & visual science·2026
Same journal

Human Crystallin Variation and Cataract.

Investigative ophthalmology & visual science·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.3K

IMI-Interventions for Controlling Myopia Onset and Progression 2025.

Mark A Bullimore1, Kathryn J Saunders2, Rigmor C Baraas3

  • 1College of Optometry, University of Houston, Houston, Texas, United States.

Investigative Ophthalmology & Visual Science
|September 17, 2025
PubMed
Summary
This summary is machine-generated.

Effective myopia control interventions are increasingly available, addressing a major public health issue. Research continues to explore new treatments to slow myopia progression and onset.

More Related Videos

Inducement and Evaluation of a Murine Model of Experimental Myopia
07:20

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

10.5K
Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
05:26

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

2.5K

Related Experiment Videos

Last Updated: Jan 17, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.3K
Inducement and Evaluation of a Murine Model of Experimental Myopia
07:20

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

10.5K
Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
05:26

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

2.5K

Area of Science:

  • Ophthalmology
  • Public Health
  • Optometry

Background:

  • Myopia is a significant global public health concern, especially in East and Southeast Asia.
  • Numerous interventions have been developed to manage myopia onset and progression.
  • Treatment options have expanded since the 2019 International Myopia Institute review.

Purpose of the Study:

  • To review the efficacy of various myopia control interventions.
  • To categorize interventions into optical, pharmacological, environmental, colored light, and surgical approaches.
  • To assess the current landscape of myopia management strategies.

Main Methods:

  • Review of randomized controlled trials for established myopia control technologies.
  • Inclusion of data on emerging treatments where available.
  • Synthesis of evidence across different intervention categories.

Main Results:

  • Multiple effective interventions exist across most tested categories.
  • Optical, pharmacological, and environmental strategies show promise.
  • Efficacy data for emerging treatments remain limited.

Conclusions:

  • Several effective interventions are available for myopia control.
  • Further research is needed to understand myopia progression mechanisms.
  • Developing more effective treatments requires deeper insight into underlying processes.